NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lindy Biosciences

Lindy Biosciences

Private
Morrisville, North CarolinaHealthcare & Life Scienceshttps://www.lindybio.com/

Last Round

Corporate Funding

Aug 28, 2024

Total Funding Raised

$25.55M

Company Overview

Lindy Biosciences is a biotechnology company that develops a proprietary microglassification platform to enable the subcutaneous administration of highly concentrated biologic drug suspensions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

protein formulationsubcutaneous deliverybiologicsdrug deliverymonoclonal antibodiesdrug formulationbiotech licensinghome injectionself-administrationviscosity reductionbiopharma partnershipdrug delivery techsub-q deliverybiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lindy Biosciences Comparables

Compare Lindy Biosciences with similar companies based on industry and business-model similarity.

Lindy Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AcousticaBio
87%
Bhami's Research Laboratory Private Limited
86%
ALTEOGEN Inc.
76%

Lindy Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingAug 28, 2024
Series BMar 11, 2022
DebtAug 3, 2020

Key People

Founding team and executive leadership

Deborah Bitterfield

CEO & Founder

Founding Team

Gary Vinson

Chief Operating Officer

Executive Team

Lindy Biosciences Investors

Notable investors and investment history

Lindy Biosciences investors
InvestorRounds
Good Growth CapitalSeries B, Series A
Fulcrum Financial ServicesSeries B
IAG Capital PartnersSeries B
AlumsharesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 95% MoM, reaching 1.5K.

Lindy Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lindy Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lindy Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMorrisville, North Carolina
Employee Range23
Year Founded2016
Last FundingAug 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.